Analyze Diet
Journal of veterinary pharmacology and therapeutics1992; 15(4); 351-363; doi: 10.1111/j.1365-2885.1992.tb01027.x

Vancomycin kinetics in plasma and synovial fluid following intravenous administration in horses.

Abstract: Vancomycin hydrochloride was infused intravenously (i.v.) over a 30-min period in five horses at doses of 6.6, 11.0 and 15.4 mg/kg. Vancomycin concentration in plasma and synovial fluid samples was measured using a polarization immunoassay. A pharmacokinetic model was developed to accommodate the special features of the present study. The data were described by a two compartment open model with synovial fluid as an additional compartment in exchange with plasma. Minimum inhibitory concentration (MIC) and minimum bacterial concentration (MBC) were measured for Staphylococcus aureus and Enterococcus sp. using isolates from hospital patients. Based on the pharmacokinetic model and MIC/MBC data, a practical therapeutic protocol for vancomycin administration was established at doses of 4.3-7.5 mg/kg given as a 1-h infusion every 8 h.
Publication Date: 1992-12-11 PubMed ID: 1487834DOI: 10.1111/j.1365-2885.1992.tb01027.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigated how the drug Vancomycin, when given to horses intravenously, affects the plasma and synovial fluid. The study established a protocol for vancomycin administration by modeling the pharmacokinetics, measuring the antibiotic’s minimum inhibitory concentration and minimal bacterial concentration against Staphylococcus aureus and Enterococcus species.

Research Methodology

  • The study involved administering Vancomycin hydrochloride intravenously to five horses. The doses given were 6.6, 11.0, and 15.4 mg/kg. The infusion process lasted for 30 minutes.
  • The Vancomycin concentration in the plasma and synovial fluid of these horses was measured using polarization immunoassay, a technique used to quantify the amount of a substance in a solution.
  • A pharmacokinetic model was developed to accommodate the particular aspects of this study.

Pharmacokinetic Model

  • The data was analyzed using a two-compartment open model, wherein the synovial fluid was considered an additional compartment exchanging with plasma.
  • This model describes how the drug is absorbed, distributed, metabolized, and excreted, providing a theoretical framework that reflects the process of drug treatment in horses.

Minimum Inhibitory Concentration (MIC) and Minimum Bacterial Concentration (MBC)

  • The MIC and MBC were determined for two bacteria: Staphylococcus aureus and Enterococcus species. These two were chosen because they are common in hospital settings and are typically resistant to many antibiotics.
  • The use of clinical isolates from hospital patients helps to accurately represent potential real-world infections in the MIC and MBC testing.
  • The MIC is the lowest concentration of an antimicrobial that can inhibit the visible growth of a microorganism, and the MBC is the lowest concentration of an antimicrobial that results in microbial death.

Establishing a Therapeutic Protocol

  • Basing on the results of the pharmacokinetic model and the MIC/MBC data, a practical therapeutic protocol was developed for administering Vancomycin in horses.
  • This protocol prescribed doses of 4.3-7.5 mg/kg to be given as a 1-hour infusion every 8 hours to ensure effectiveness and safety of the drug in horses.

Cite This Article

APA
Orsini JA, Ramberg CF, Benson CE, Dreyfuss DJ, Vecchione JA, Kunz CC. (1992). Vancomycin kinetics in plasma and synovial fluid following intravenous administration in horses. J Vet Pharmacol Ther, 15(4), 351-363. https://doi.org/10.1111/j.1365-2885.1992.tb01027.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 15
Issue: 4
Pages: 351-363

Researcher Affiliations

Orsini, J A
  • Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania.
Ramberg, C F
    Benson, C E
      Dreyfuss, D J
        Vecchione, J A
          Kunz, C C

            MeSH Terms

            • Animals
            • Bacterial Infections / drug therapy
            • Bacterial Infections / veterinary
            • Enterococcus / drug effects
            • Horse Diseases / drug therapy
            • Horses / metabolism
            • Infusions, Intravenous
            • Joint Diseases / drug therapy
            • Joint Diseases / veterinary
            • Microbial Sensitivity Tests
            • Models, Biological
            • Staphylococcus aureus / drug effects
            • Synovial Fluid / metabolism
            • Vancomycin / administration & dosage
            • Vancomycin / blood
            • Vancomycin / pharmacokinetics
            • Vancomycin / pharmacology

            Citations

            This article has been cited 2 times.
            1. Isguven S, Fitzgerald K, Delaney LJ, Harwood M, Schaer TP, Hickok NJ. In vitro investigations of Staphylococcus aureus biofilms in physiological fluids suggest that current antibiotic delivery systems may be limited. Eur Cell Mater 2022 Feb 2;43:6-21.
              doi: 10.22203/eCM.v043a03pubmed: 35106744google scholar: lookup
            2. Orsini JA, Snooks-Parsons C, Stine L, Haddock M, Ramberg CF, Benson CE, Nunamaker DM. Vancomycin for the treatment of methicillin-resistant staphylococcal and enterococcal infections in 15 horses. Can J Vet Res 2005 Oct;69(4):278-86.
              pubmed: 16479726